Genmab A/S Files Form 6-K for November 2024
Ticker: GNMSF · Form: 6-K · Filed: Nov 27, 2024 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Nov 27, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
Genmab A/S filed a 6-K for Nov 2024, nothing major, just standard reporting.
AI Summary
Genmab A/S filed a Form 6-K on November 27, 2024, to report information for the month of November 2024. This filing is incorporated by reference into Genmab A/S's existing S-8 registration statements.
Why It Matters
This filing serves as an update for investors and the market regarding Genmab A/S's ongoing reporting requirements.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new material financial or operational information.
Key Players & Entities
- Genmab A/S (company) — Registrant
- 0001558370-24-015939 (filing_id) — Accession Number
- 20241127 (date) — Filing Date
- Form 6-K (document_type) — Filing Type
- Form S-8 (document_type) — Incorporated by reference into registration statements
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to furnish information which it makes or is required to make public pursuant to the laws of its home country or jurisdiction of incorporation or organization, or which it furnishes or makes public to its security holders.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is November 27, 2024.
Which registration statements does this filing get incorporated into?
This filing is incorporated by reference into Genmab A/S's registration statements on Form S-8 (File No. 333-232693, 333-253519, 333-262970 and 333-277273).
What is Genmab A/S's principal executive office address?
Genmab A/S's principal executive office is located at Carl Jacobsens Vej 30, 2500 Valby, Denmark.
Is Genmab A/S required to file annual reports under Form 20-F or Form 40-F?
Genmab A/S indicates it files annual reports under Form 20-F.
Filing Stats: 210 words · 1 min read · ~1 pages · Grade level 14.1 · Accepted 2024-11-27 12:54:51
Filing Documents
- tmb-20241127x6k.htm (6-K) — 19KB
- tmb-20241127xex3d1.htm (EX-3.1) — 274KB
- 0001558370-24-015939.txt ( ) — 294KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE MONTH OF NOVEMBER 2024 COMMISSION FILE NUMBER 001-38976 Genmab A/S (Exact name of Registrant as specified in its charter) Carl Jacobsens Vej 30 2500 Valby Denmark +45 70 20 27 28 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F This report on Form 6-K shall be deemed to be incorporated by reference in Genmab A/S's registration statements on Form S-8 (File No. 333-232693, 333-253519, 333-262970 and 333-277273 ) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GENMAB A/S BY: /s/ Anthony Pagano Name: Anthony Pagano Title: Executive Vice President & Chief Financial Officer DATE: NOVEMBER 27, 2024 EXHIBIT INDEX Exhibit Description of Exhibit 3.1 Articles of Association